Table 1 Patient demographics and clinical characteristics for patients of CN and NS group
CN (N = 6043) | NS (N = 489) | Overall (N = 6532) | |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 60.7 (11.5) | 69.5 (12.9) | 61.3 (11.8) |
Median [Min, Max] | 61.0 [8.00, 95.0] | 71.0 [32.0, 95.0] | 61.0 [8.00, 95.0] |
Sex | |||
Female | 1798 (29.8%) | 193 (39.5%) | 1991 (30.5%) |
Male | 4245 (70.2%) | 296 (60.5%) | 4541 (69.5%) |
Race | |||
Black | 478 (7.9%) | 71 (14.5%) | 549 (8.4%) |
Other | 439 (7.3%) | 42 (8.6%) | 481 (7.4%) |
White | 5126 (84.8%) | 376 (76.9%) | 5502 (84.2%) |
T stage | |||
T1 | 749 (12.4%) | 180 (36.8%) | 929 (14.2%) |
T2 | 886 (14.7%) | 121 (24.7%) | 1007 (15.4%) |
T3 | 3926 (65.0%) | 134 (27.4%) | 4060 (62.2%) |
T4 | 482 (8.0%) | 54 (11.0%) | 536 (8.2%) |
N stage | |||
N0 | 4243 (70.2%) | 324 (66.3%) | 4567 (69.9%) |
N1 | 1800 (29.8%) | 165 (33.7%) | 1965 (30.1%) |
Histologic type | |||
Chromophobe | 74 (1.2%) | 2 (0.4%) | 76 (1.2%) |
Clear Cell | 4582 (75.8%) | 401 (82.0%) | 4983 (76.3%) |
Papillary | 314 (5.2%) | 14 (2.9%) | 328 (5.0%) |
other | 1073 (17.8%) | 72 (14.7%) | 1145 (17.5%) |
Survival time (months) | |||
Mean (SD) | 26.6 (28.6) | 11.8 (18.9) | 25.5 (28.3) |
Median [Min, Max] | 17.0 [0, 155] | 5.00 [0, 130] | 15.0 [0, 155] |